Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 2
2009 1
2010 1
2012 1
2016 2
2017 1
2018 1
2019 2
2020 1
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean skog e[au] (87 results)?
Primary pulmonary choriocarcinoma.
Snoj Z, Kocijancic I, Skof E. Snoj Z, et al. Among authors: skof e. Radiol Oncol. 2016 Jun 24;51(1):1-7. doi: 10.1515/raon-2016-0038. eCollection 2017 Mar 1. Radiol Oncol. 2016. PMID: 28265226 Free PMC article.
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis.
Poveda A, Lheureux S, Colombo N, Cibula D, Lindemann K, Weberpals J, Bjurberg M, Oaknin A, Sikorska M, González-Martín A, Madry R, Pérez MJR, Ledermann J, Davidson R, Blakeley C, Bennett J, Barnicle A, Škof E. Poveda A, et al. Among authors: skof e. Gynecol Oncol. 2022 Mar;164(3):498-504. doi: 10.1016/j.ygyno.2021.12.025. Epub 2022 Jan 19. Gynecol Oncol. 2022. PMID: 35063276 Free article. Clinical Trial.
Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing.
Stegel V, Blatnik A, Škof E, Dragoš VŠ, Krajc M, Gregorič B, Škerl P, Strojnik K, Klančar G, Banjac M, Žgajnar J, Ravnik M, Novaković S. Stegel V, et al. Among authors: skof e. Cancers (Basel). 2022 Mar 10;14(6):1434. doi: 10.3390/cancers14061434. Cancers (Basel). 2022. PMID: 35326583 Free PMC article.
Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high-grade serous carcinoma from ascites.
Miceska S, Škof E, Novaković S, Stegel V, Jeričević A, Grčar Kuzmanov B, Smrkolj Š, Cvjetičanin B, Bebar S, Globočnik Kukovica M, Kloboves-Prevodnik V. Miceska S, et al. Among authors: skof e. Cancer Cytopathol. 2023 Mar;131(3):188-197. doi: 10.1002/cncy.22664. Epub 2022 Nov 18. Cancer Cytopathol. 2023. PMID: 36399410 Free article.
24 results